Jan. 29, 2020

Winship Invest$ names pilot grant recipients

Photo of Winship Invest$ names pilot grant recipients

Twelve Winship investigators will receive over $750,000 in funding for new cancer research projects through Winship Invest$.

Twelve Winship investigators will receive over $750,000 in funding for new cancer research projects through Winship Invest$. The selected proposals include two pilot grants funded in part by contributions from the Oliver S. and Jennie R. Donaldson Charitable Trust.

Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research, is supported by philanthropic contributions as well as developmental funds from Winship's Cancer Center Support Grant (P30CA138292) awarded by the National Cancer Institute of the National Institutes of Health.

This cycle's Winship Invest$ pilot grant recipients are:

  • Machine learning for inferencing of HCC risk from medical imaging
    Imon Banerjee, PhD
  • A Novel Enzymatic Immunotherapy that Targets Adenosine
    John Blazeck, PhD
  • The Role of EGFR family in Cytokine/Chemokine-mediated Immune Suppression in Squamous Cell Carcinoma of the Head and Neck
    Georgia Chen, PhD
  • Effects of low dietary fat and/or combined statin treatments on efficacy of BRAF or MEK1 inhibitors in mouse models of BRAF V600E-expressing melanoma
    Jing Chen, PhD
  • The biological mechanism of a novel anti-cancer drug in overcoming drug resistance
    Sumin Kang, PhD
  • Elucidating Mechanisms of an Endocrine Disrupting Chemical in the Development of Endocrine-Sensitive Cancers
    Lauren McCullough, PhD, MSPH
  • Targeting leukemic stem cells by inducing bioenergetic stress and cell cycle arrest
    Cheng-Kui Qu, PhD
  • Enabling drug-resistance overcoming by a catalytic nanodrug targeting caner antioxidative system
    Jie Song, PhD, MSc
  • Deciphering the function and impact of N-terminal Histone H3 lysine conversions as oncohistones
    Jennifer Spangle, PhD
  • Identifying the Impact of Chronic Psychosocial Stress on Tumor Immunity in Breast Cancer Patients
    Jennifer Stevens, PhD

The Donaldson Charitable Trust Research Synergy Fund is intended to spark collaboration between basic researchers (including biomedical engineers) and physicians, leading to innovations that improve the lives of children and adults with cancer. This funding opportunity was offered jointly by Winship Cancer Institute, the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, and the Wallace H. Coulter Biomedical Engineering Department at Emory University and the Georgia Institute of Technology.

This cycle's Donaldson Charitable Trust Research Synergy Fund pilot grant recipients are:

  • Characterizing immune reconstitution in lymphoma patients who receive chimeric antigen receptor T-cell (CAR-T) therapy
    Jean Koff, MD
  • Portable CBC: Patient-operated, home-based, portable complete blood counter
    Francisco Robles, PhD

For more info, contact:

Cascade Link  TOP